Loading...

Purified anti-Tubulin β-3 (TUBB3) Antibody (Previously Covance catalog# PRB-435P)

Pricing & Availability
Clone
Poly18020 (See other available formats)
Regulatory Status
RUO
Other Names
CDCBM, CDCBM1, CFEOM3, CFEOM3A, FEOM3, TUBB4, Tubulin beta-3 chain, tubulin beta-III, TUBB3, tubulin beta-4 chain, class III beta-tubulin
Previously
Covance Catalog# PRB-435P
Isotype
Rabbit Polyclonal IgG
Ave. Rating
Submit a Review
Product Citations
publications
A_Poly18020_PURE_Tubulin_beta3_IHCP_1_032918
IHC staining of purified anti-Tubulin β-3 (TUBB3) antibody (Poly18020) on formalin-fixed paraffin-embedded rat cerebellum. Following antigen retrieval using Sodium Citrate H.I.E.R., the tissue was incubated with 0.1 µg/mL of the primary antibody overnight at 4°C. BioLegend’s Ultra Streptavidin (USA) HRP Detection Kit (Multi-Species, DAB, Cat. No. 929901) was used for detection followed by hematoxylin counterstaining, according to the protocol provided. The image was captured with a 40X objective. Scale bar: 50 µm
  • A_Poly18020_PURE_Tubulin_beta3_IHCP_1_032918
    IHC staining of purified anti-Tubulin β-3 (TUBB3) antibody (Poly18020) on formalin-fixed paraffin-embedded rat cerebellum. Following antigen retrieval using Sodium Citrate H.I.E.R., the tissue was incubated with 0.1 µg/mL of the primary antibody overnight at 4°C. BioLegend’s Ultra Streptavidin (USA) HRP Detection Kit (Multi-Species, DAB, Cat. No. 929901) was used for detection followed by hematoxylin counterstaining, according to the protocol provided. The image was captured with a 40X objective. Scale bar: 50 µm
  • B_Poly18020_PURE_Tubulin_beta3_IHCP_2_032918
    IHC staining of purified anti-Tubulin β-3 (TUBB3) antibody (Poly18020) on formalin-fixed paraffin-embedded human cerebellum. Following antigen retrieval using Sodium Citrate H.I.E.R., the tissue was incubated with 0.1 µg/mL of the primary antibody overnight at 4°C. BioLegend’s Ultra Streptavidin (USA) HRP Detection Kit (Multi-Species, DAB, Cat. No. 929901) was used for detection followed by hematoxylin counterstaining, according to the protocol provided. The image was captured with a 40X objective. Scale bar: 50 µm
  • C_Poly18020_PURE_Tubulin_beta3_IHCP_3_032918
    IHC staining of purified anti-Tubulin β-3 (TUBB3) antibody (Poly18020) on formalin-fixed paraffin-embedded human cerebellum. Following antigen retrieval using Sodium Citrate H.I.E.R., the tissue was incubated with 0.1 µg/mL of the primary antibody overnight at 4°C. BioLegend’s Ultra Streptavidin (USA) HRP Detection Kit (Multi-Species, DAB, Cat. No. 929901) was used for detection followed by hematoxylin counterstaining, according to the protocol provided. The image was captured with a 40X objective. Scale bar: 50 µm
  • Poly18020_PURE_Tubulin_beta3_WB_021915.jpg
    Western blot of purified anti-Tubulin β-3 (TUBB3) antibody (Poly18020). Lane 1: Molecular weight marker; Lane 2: 20 µg of human brain lysate; Lane 3: 20 µg of mouse brain lysate; Lane 4: 20 µg of rat brain lysate. The blots were incubated with 0.1 µg/mL of Poly18020 or Rabbit IgG overnight at 4°C, followed by incubation with HRP-labeled anti-rabbit IgG (Cat. No. 410406). Enhanced chemiluminescence was used as the detection system.
Cat # Size Price Quantity Check Availability Save
802001 100 µL 347€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Tubulin is the main component of microtubules. In adults, tubulin beta 3 (TUBB3) is primarily expressed in neurons and is commonly used as a neuronal marker. It plays an important role in neuronal cell proliferation and differentiation. Mutations in this gene cause congenital fibrosis of the type 3 extraocular muscles. Tubulin beta 3 (TUBB3) is also found in a wide range of tumors. Studies indicate that it is a predictive and prognostic marker in various tumors.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human, Mouse, Rat
Antibody Type
Polyclonal
Host Species
Rabbit
Immunogen
This antibody was raised against microtubules derived from rat brain.
Formulation
Phosphate-buffered solution + 0.03% Thimerosal + 50% Glycerol.
Preparation
The antibody was purified by affinity chromatography.
Concentration
1.0 mg/ml
Storage & Handling
Store between 2°C and 8°C.
Application

IHC-P - Quality tested
WB - Verified
ICC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by formalin-fixed paraffin-embedded immunohistochemical staining. For immunohistochemistry, a concentration range of 0.1 - 0.5 µg/mL is suggested. For Western blotting, the suggested use of this reagent is 0.1 - 0.5 µg/mL. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: immunocytochemistry (ICC).

This antibody is well characterized and highly reactive to neuron specific Class III ß-Tubulin (ßIII), but does not identify ß-tubulin found in glial cells. This product may contain other non-IgG subtypes.

Application References

(PubMed link indicates BioLegend citation)
  1. Feuer R, et al. 2005. J. Neurosci. 25(9):2434-44.
  2. Mozzetti S, et al. 2005. Clin. Cancer Res. 11(1):298-305.
  3. Feuer R, et al. 2003. Am. J. Pathol. 163(4):1379-93.
  4. Zhang XM, Yang XJ. 2001. Development. 128(6):943-57.
  5. Ma M, et al. 2012. Neurobiol Dis. 56:34. (WB) PubMed
  6. Tseung G, et al. 2011. J. Virol. 85:5718. (IF) PubMed
  7. Shimada IS, et al. 2012. J Neurosci. 32:7926. (IHC) PubMed
  8. Flores-Otero J, et al. 2007. J. Neurosci. 27:14023. (IF) PubMed
Product Citations
  1. Chow A, Morshead C 2016. Stem Cell Res. 16:79-87. PubMed
  2. Son M, et al. 2016. Exp Mol Med. 48: 232. PubMed
  3. Hoshino N, et al. 2021. Journal of Comparative Neurology. 529:3633. PubMed
  4. Tseng K, et al. 2017. eNeuro. 10.1523/ENEURO.0214-17.2017. PubMed
  5. Ahangari N, et al. 2021. J Neuropathol Exp Neurol. 80:944. PubMed
  6. Samarasinghe RA, et al. 2021. Nat Neurosci. 24:1488. PubMed
  7. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  8. Tian E, et al. 2016. Cell Rep. 16: 781-792. PubMed
  9. Baleriola J, et al. 2016. Sci Rep. 6: 25928. PubMed
  10. Shimada I, et al. 2012. J Neurosci. 32:7926-7940. PubMed
  11. Arber C, et al. 2019. Brain Commun. 1:fcz024. PubMed
  12. Jiang Y, et al. 2018. J Biol Chem. 293:19317. PubMed
  13. Stokowska A, et al. 2017. Brain. 140:353. PubMed
  14. Eltahir MK, et al. 2022. PLoS One. 17:e0269683. PubMed
  15. Pardieck J, et al. 2021. Stem Cells Dev. 30:816. PubMed
  16. Kim S, et al. 2021. Nat Commun. 12:1807. PubMed
  17. Krishnan V, et al. 2016. J Neuropathol Exp Neurol. 75: 464 - 478. PubMed
  18. Brosig A, et al. 2019. Cell Rep. 29:2028. PubMed
  19. Girouard MP, et al. 2020. eneuro. 7(2):ENEURO. PubMed
  20. Meng QT, et al. 2021. Elife. 10:. PubMed
  21. Olmsted ZT, et al. 2022. Front Cell Neurosci. 15:725195. PubMed
  22. Binder J, et al. 2022. Commun Biol. 5:125. PubMed
  23. Nichterwitz S, et al. 2020. Genome Res. 30:1083. PubMed
  24. Vogt M, et al. 2021. Theranostics. 11:5569. PubMed
  25. Pires G, et al. 2021. Brain Commun. 3:fcab021. PubMed
  26. Brykczynska U, et al. 2016. Stem Cell Reports. 7:1059-1071. PubMed
  27. Omichi R, et al. 2020. Mol Ther Methods Clin Dev. 1.51875. PubMed
  28. Xie Y, et al. 2018. Stem Cell Res. 9:2010. PubMed
  29. Uezono N, et al. 2018. Stem Cells. 36:737. PubMed
  30. Tang SC, et al. 2017. Diabetologia. 61:158. PubMed
  31. MOSES C, et al. 2020. Sci Rep. 10:11393. PubMed
  32. Nayak G, et al. 2020. Cell Reports. 30(3):672-686.e8.. PubMed
  33. Jo S, et al. 2021. Stem Cell Research. 56:102524. PubMed
  34. Gong C, et al. 2021. Cell Reports. 34(12):108889. PubMed
  35. Kurihara Y, et al. 2020. Journal of Neurochemistry. 155(3):285-299. PubMed
  36. Hastings RL, et al. 2020. Sci Rep. 10:11132. PubMed
  37. Hoffman LF, et al. 2018. J Assoc Res Otolaryngol. 19:33. PubMed
  38. Carlin D et al. 2018. eNeuro. 5(2) pii: ENEURO. PubMed
  39. Dvoriantchikova G, et al. 2022. Sci Rep. 12:17152. PubMed
  40. Boland M, et al. 2017. Brain. 10.1093/brain/aww357. PubMed
  41. Ou MY, et al. 2021. Cell Reports. 35(13):109290. PubMed
  42. Sakaguchi H, et al. 2019. Stem Cell Reports. 13:458. PubMed
  43. Voronova A et al. 2017. Neuron. 94(3):500-516 . PubMed
  44. Sabelström H, et al. 2019. Cell Rep. 28:2064. PubMed
  45. Mertens J, et al. 2021. Cell Stem Cell. 28:1533. PubMed
  46. Otani T, et al. 2016. Cell Stem Cell. 18: 467-480. PubMed
  47. Verstraelen P, et al. 2017. Front Cell Neurosci. 11:173. PubMed
  48. Kim H et al. 2017. Stem cell research. 26:72-75 . PubMed
  49. Li H, et al. 2019. iScience. 19:559. PubMed
  50. van Niekerk EA, et al. 2022. Cell Rep Methods. 2:100255. PubMed
  51. Avraham O, et al. 2021. Elife. 10:. PubMed
  52. Simone R, et al. 2021. Nature. 594:117. PubMed
  53. Lasagni Vitar RM, et al. 2021. Invest Ophthalmol Vis Sci. 62:26. PubMed
  54. Reddy A, et al. 2020. Cell. 183:62. PubMed
  55. Macpherson P, et al. 2015. Development. 142: 4038 - 4048. PubMed
  56. Ferguson M, et al. 2013. Neurobiol Dis. 56:34-46. PubMed
  57. Yau K, et al. 2016. J Neurosci. 36: 1071 - 1085. PubMed
  58. Cui Q, et al. 2016. Nat Commun. 7:10637. PubMed
  59. Bosze B, et al. 2020. J Neurosci. 40:1501. PubMed
  60. Benoy V, et al. 2018. Brain. 10.1093/brain/awx375. PubMed
  61. Chabrat A, et al. 2019. Stem Cells Int. 2019:2945435. PubMed
  62. Yang C, et al. 2020. Neuron. 105:276. PubMed
  63. Suter TACS, et al. 2020. Cell Rep. 30:1164. PubMed
  64. Adams MT, et al. 2021. eLife. 0.416666666666667. PubMed
  65. Iannielli A, et al. 2019. Cell Rep. 29:4646. PubMed
  66. Bowles KR, et al. 2019. PLoS One. 14:e0213374. PubMed
  67. Toda T, et al. 2017. Cell Stem Cell. 21:618. PubMed
  68. Qiang L et al. 2018. Current biology : CB. 28(13):2181-2189 . PubMed
  69. Meijer M et al. 2019. Cell Rep. 27(7):2199-2211 . PubMed
  70. Amador A, et al. 2020. Brain. 143:2039. PubMed
  71. Sugiyama T, et al. 2021. iScience. 24(7):102758. PubMed
  72. Bhaskaran S, et al. 2020. Aging Cell. 19:e13225. PubMed
  73. Rhee HJ et al. 2019. Cell Rep. 27(7):2212-2228 . PubMed
  74. Makar T, et al. 2018. Stem Cell Res Ther. 9:127. PubMed
  75. Zahr SK et al. 2018. Neuron. 97(3):520-537 . PubMed
  76. Finno CJ, et al. 2022. Front Cell Neurosci. 16:853035. PubMed
  77. Newland B, et al. 2021. ACS Chem Neurosci. 12:1178. PubMed
  78. Cora V, et al. 2019. Cells. 8:5. PubMed
  79. Grove M, et al. 2020. eLife. 9:e50138.. PubMed
  80. Huang S, et al. 2020. Cell. 184(2):441-459.e25. PubMed
  81. Lin P, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G412 - G422. PubMed
  82. Tsueng G, et al. 2011. J Virol. 85:5718-5732. PubMed
  83. Alvarez–Lindo N, et al. 2019. Sci Rep. 9:18486. PubMed
  84. Tiwari D et al. 2019. Neurobiol Dis. 1871:48:00 . PubMed
  85. Carlin D et al. 2019. eNeuro. 6(3) pii: ENEURO. PubMed
  86. Li H, et al. 2018. Hum Mutat. 39:550. PubMed
  87. Francistiová L, et al. 2022. Front Mol Neurosci. 14:793769. PubMed
  88. Iennaco R, et al. 2022. Cell Death Differ. 29:293. PubMed
  89. Bjorke B, et al. 2021. Dev Biol. 476:272. PubMed
  90. Watanabe S, et al. 2016. EMBO Mol Med. 8(12):1421-1437. PubMed
  91. Cates K, et al. 2020. Cell Stem Cell. 28(1):127-140.e9. PubMed
  92. Ou J et al. 2018. Cell. 173(4):851-863 . PubMed
  93. Hsu J, et al. 2019. Nat Commun. 10:2939. PubMed
  94. Chanda S et al. 2019. Cell Stem Cell. 25(1):103-119 . PubMed
  95. Peitz M, et al. 2020. STAR Protoc. 1:100038. PubMed
  96. Smith LA, et al. 2021. Front Cell Dev Biol. 9:667246. PubMed
  97. Mao Y, et al. 2021. Cell Prolif. 54:e13090. PubMed
  98. Olmsted ZT, et al. 2022. iScience. 25:104486. PubMed
  99. Vahsen BF, et al. 2022. Sci Rep. 12:12606. PubMed
  100. Vicidomini C, et al. 2016. Mol Psychiatry. 10.1038/mp.2016.30. PubMed
  101. Barry DM, et al. 2020. Nat Commun. 11:1397. PubMed
  102. Hattori Y, et al. 2020. Nat Commun. 11:1631. PubMed
  103. Duncan DS, et al. 2018. Front Neurosci. 0.9875. PubMed
  104. Martínez JC et al. 2019. Neuron. 104(5):931-946 . PubMed
  105. Mickle AD, et al. 2019. Nature. 565:361. PubMed
  106. Kawakami Y et al. 2018. The Journal of Neuroscience. 38(10):2589-2604 . PubMed
  107. Flitsch LJ, et al. 2022. Sci Rep. 12:8356. PubMed
  108. Pahl MC, et al. 2021. Nat Commun. 12:6749. PubMed
  109. Kim H, et al. 2020. Sci Signal. 13: . PubMed
  110. Flores-Otero J, et al. 2007. J Neurosci. 27:14023-14034. PubMed
  111. Zhang L, et al. 2016. Neuroscience. 337:88-97. PubMed
  112. Arber C, et al. 2021. Cell Reports. 34(2):108615. PubMed
  113. Shah K, et al. 2019. J Mol Cell Biol. N/A. PubMed
  114. Sar Shalom H, et al. 2019. Elife. 8:e41162. PubMed
  115. Facchin C, et al. 2020. Theranostics. 10:3518. PubMed
  116. Besusso D, et al. 2020. Stem Cell Res. 102016:49. PubMed
  117. Shang Y, et al. 2018. J Neurosci. 38:4006. PubMed
  118. Jean-Louis T, et al. 2018. Neurobiol Aging. 62:130. PubMed
  119. Baker L, et al. 2021. JCI Insight. 6:. PubMed
  120. Arber C, et al. 2020. Mol Psychiatry. 25:2919. PubMed
  121. Smith-Anttila CJA, et al. 2021. Developmental Biology. 476:18-32. PubMed
  122. Hung C, et al. 2021. Cell Reports. 35(11):109259. PubMed
  123. Ornaghi F, et al. 2020. Neurobiol Dis. 134:104667. PubMed
  124. Hung COY et al. 2018. Cell reports. 25(13):3647-3660 . PubMed
  125. Jeon H, et al. 2018. J Clin Med. 7:. PubMed
  126. Dan W, et al. 2022. Front Physiol. 12:744294. PubMed
  127. Avraham O, et al. 2022. Front Mol Neurosci. 14:796070. PubMed
  128. Jacob L, et al. 2022. J Exp Med. 219:. PubMed
  129. Olmsted ZT, et al. 2021. iScience. 24(8):102827. PubMed
  130. Ward AI, et al. 2020. MBio. 11:00. PubMed
  131. Avraham O, et al. 2020. Nat Commun. 3.854861111. PubMed
  132. Anastasiadou S, Knöll B 2016. Exp Neurol. 279:243-260. PubMed
  133. Lee J, et al. 2018. J Clin Med. 7:. PubMed
  134. Avraham O, et al. 2022. Front Mol Neurosci. 15:967472. PubMed
  135. Su Y, et al. 2021. Int J Mol Sci. 22:. PubMed
RRID
AB_2564645 (BioLegend Cat. No. 802001)

Antigen Details

Cell Type
Mature Neurons, Neural Stem Cells
Biology Area
Cell Biology, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
Microtubules
Gene ID
10381 View all products for this Gene ID
UniProt
View information about Tubulin beta-3 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 4    Revision Date: 10.24.2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account